FIELD: chemistry.
SUBSTANCE: present invention relates to a topical spray composition for treating wounds or injuries containing 1 to 10 wt. % tranexamic acid, from 0.1 to 1 wt. % chitosan, from 1 to 5 wt. % polyethylene glycol, from 0.1 to 1 wt. % polysorbate 80, from 0.1 to 0.5 wt. % polyvinylpyrrolidone, glacial acetic acid and water.
EFFECT: technical result of the present invention is the development of a pharmaceutical spray composition for treating wounds or injuries, in particular for use as haemostatic composition for topical application or in case of surgical intervention.
5 cl, 7 ex, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
HAEMOSTATIC SPRAYS AND COMPOSITIONS | 2005 |
|
RU2377022C9 |
HEMOSTATIC COMPOSITION COMPRISING HYALURONIC ACID | 2005 |
|
RU2369408C2 |
HAEMOSTATIC COMPOSITION CONTAINING HYALURONIC ACID | 2009 |
|
RU2486921C2 |
COMPOSITION FOR TEMPORARY CONTROL OF BLEEDING | 2023 |
|
RU2819603C1 |
LOCAL HEMOSTATIC AGENT | 2023 |
|
RU2807892C1 |
HAEMOSTATIC POWDER | 2020 |
|
RU2820476C2 |
HAEMOSTATIC COMPOSITION | 2016 |
|
RU2741304C2 |
MULTILAYER COMBINED LOCAL HAEMOSTATIC AGENT | 2023 |
|
RU2826069C1 |
HEMOSTATIC BIOLOGICALLY ABSORBABLE DEVICE WITH POLYETHYLENE GLYCOL AS A BINDING SUBSTANCE | 2012 |
|
RU2646728C1 |
HAEMOSTATIC MATERIAL | 2012 |
|
RU2824974C2 |
Authors
Dates
2020-12-28—Published
2018-09-11—Filed